Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitreous PGE2 Levels After Topical NSAIDs in Vitrectomy
NCT03597867Phase 3Completed
- Sponsor
- University of Trieste
- Start
- Apr 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac, nepafenac, indomethacin, bromfenac sodium in ocular inflammation, sponsored by University of Trieste. Started Apr 2018; status: completed.
02
Drugs
diclofenacnepafenacindomethacinbromfenac sodium
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT03597867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03597867.